1003 related articles for article (PubMed ID: 21677094)
1. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
[TBL] [Abstract][Full Text] [Related]
3. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.
Anizan S; Milman G; Desrosiers N; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2013 Oct; 405(26):8451-61. PubMed ID: 23954944
[TBL] [Abstract][Full Text] [Related]
4. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
[TBL] [Abstract][Full Text] [Related]
5. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
6. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
[TBL] [Abstract][Full Text] [Related]
8. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.
Newmeyer MN; Desrosiers NA; Lee D; Mendu DR; Barnes AJ; Gorelick DA; Huestis MA
Drug Test Anal; 2014 Oct; 6(10):1002-10. PubMed ID: 24652685
[TBL] [Abstract][Full Text] [Related]
10. On-site test for cannabinoids in oral fluid.
Desrosiers NA; Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Oct; 58(10):1418-25. PubMed ID: 22912396
[TBL] [Abstract][Full Text] [Related]
11. Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.
Scheidweiler KB; Andersson M; Swortwood MJ; Sempio C; Huestis MA
Drug Test Anal; 2017 Jan; 9(1):143-147. PubMed ID: 27539096
[TBL] [Abstract][Full Text] [Related]
12. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Schwope DM; Karschner EL; Gorelick DA; Huestis MA
Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
14. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.
Milman G; Barnes AJ; Lowe RH; Huestis MA
J Chromatogr A; 2010 Feb; 1217(9):1513-21. PubMed ID: 20083251
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
Milman G; Schwope DM; Gorelick DA; Huestis MA
Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
[TBL] [Abstract][Full Text] [Related]
17. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
18. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
Milman G; Barnes AJ; Schwope DM; Schwilke EW; Darwin WD; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Clin Chem; 2010 Aug; 56(8):1261-9. PubMed ID: 20530732
[TBL] [Abstract][Full Text] [Related]
19. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
[TBL] [Abstract][Full Text] [Related]
20. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
